Blog - Page 4861 of 5778

WednesdayApr 09, 2008 8:43 am

Aida Pharmaceuticals Inc. (AIDA.OB) Develops Wide-Spectrum Antibiotic

Aida Pharmaceuticals Inc. (OTC Bulletin Board: AIDA) today announced its recently-acquired research institute, the Jiangsu Institute of Microbiology Co. Ltd, is working toward the development of a new wide-spectrum antibiotic, Wetimicin, in the People’s Republic of China. The company believes Wetimicin will have a larger market volume than its current product, Etimicin Sulphate. Wetimicin is part of the amino-glycoside family of antibiotics, and is being tested for its efficacy in the treatment of inflammation stemming from respiratory infection, urogenital infection, soft skin tissue infection, as well as trauma from operations and more. Wetimicin’s stronger applicability to such a wide range…

WednesdayApr 09, 2008 8:38 am

Antigenics Inc. (AGEN) Receives Russian Approval of Cancer Vaccine

U.S. based Antigenics (AGEN-NASDAQ) announced on Tuesday that the Russian Ministry of Public Health has issued a registration certificate for the use of Oncophage in the treatment of kidney cancer patients at intermediate risk for disease recurrence. The company expects to launch its Oncophage product in Russia sometime in the second half of 2008. Antigenics is a biotechnology company which is developing products to treat cancer, infectious diseases, and autoimmune disorders. Their most advanced-stage product candidate is Oncophage. Oncophage is a personalized therapeutic cancer vaccine which is based on heat shock protein gp96. Antigenics is currently conducting clinical trials for…

WednesdayApr 09, 2008 8:31 am

StockGuru Blog: NextGen Bioscience (NXGB) – Potential Candidates and Acquisition Pipeline

Wednesday, April 9th, 2008 NexGen’s proprietary anti-cancer candidates include Prostaganin (targeting prostate cancer) and Tetanolic (targeting breast cancer) which have, in preliminary studies, shown to be able to target cancer cells without affecting normal tissue and therefore have potential to be developed into blockbuster drugs. These patented product candidates hold the potential to treat cancer in a way that is effective and safe for the patient. An exciting acquisition pipeline, including in oncology therapeutics, cancer vaccines and anti-bacterial drugs, ensures that the Company is constantly positioned as a leader in the forefront of developments in treating cancer and infectious disease.…

WednesdayApr 09, 2008 8:31 am

StockGuru Trade Alert: Guru Profile Kenilworth Systems (KENS) Up Over 11% Today and More than 33% in the Past Two Weeks

WednesdayApr 09, 2008 8:30 am

StockGuru Trade Alert: Guru Profile ALR Technologies (ALRT) Up Over 17% on Volume Greater than Ten-Day Average Wednesday Morning

WednesdayApr 09, 2008 8:29 am

StockGuru Trade Alert: ALR Technologies (ALRT) Now Up Over 29% with Volume More than Double Ten-Day Average

WednesdayApr 09, 2008 8:28 am

StockGuru Trade Alert: Profile Stock Tootie Pie (TOOT) Up More than 12% Intraday – Volume More than 8 Times Ten-Day Average

StockGuru Trade Alert: Profile Stock Tootie Pie (TOOT) Up More than 12% Intraday - Volume More than 8 Times Ten-Day Average Ten-Day Average: 2,539 Today’s Volume: 22,025 View the StockGuru Profile for TOOT: http://www.stockguru.com/profiles/toot/

WednesdayApr 09, 2008 8:27 am

StockGuru Trade Alert: Guru Profile Who’s Your Daddy (WYDI) Up Over 40% Intraday Wednesday and More than 95% Since Monday

StockGuru Trade Alert: Guru Profile Who’s Your Daddy (WYDI) Up Over 40% Intraday Wednesday and More than 95% Since Monday WYDI Has Moved from $0.23 to $0.45 Since Monday! Today’s Volume is More than 7 Times the Ten-Day Average! Ten-Day Average: 45,042 Today’s Volume: 322,359

WednesdayApr 09, 2008 8:20 am

StockGuru News: China Voice (CHVC) Announces Agreement with China Netcom — Company Expects Partnership to Drive Revenues to $327 Million

StockTalkJournal: Who is China Voice? BOCA RATON, Fla.–China Voice Holding Corporation, announced today that it has entered into a partnership and revenue sharing agreement with China Netcom. The previously announced original agreement has been amended to provide for a true partnership with CHVC. The changes to the agreement include the use of allocated funds originally targeted for Candidsoft Software licenses to be used to provide connectivity, network expansion, installation, billing, collection and on-going support of CHVC’s government contracts. The initial phase of the new agreement is for the GuangXi Autonomous Region where CHVC has contracts for the installation of its…

WednesdayApr 09, 2008 8:14 am

StockGuru Stocks to Watch for Wednesday, April 9, 2008 Featuring NextGen Bioscience, China Voice, Sports Pouch Beverage and KCM Holdings

NextGen Bioscience, Inc. (OTC: NXGB) NextGen Bioscience, Inc. (OTC: NXGB) - Tuesday’s shares decreased 40% to $0.24. 427,300 shares were traded. NextGen Bioscience announced April 8th it acquired use, commercialisation and ownership rights of a patent application for the treatment of cancer from Oxon Life Science Inc. The patent application describes an improved method of identifying and purifying undifferentiated stem cells from solid breast carcinomas that are normally resistant to conventional therapies. The cancer stem cell is typically represented as a distinct population of cells within a tumour which may remain even if the rest of the tumour is destroyed,…

Site Search

Company Search